ASKER.ST Stock — Price, Charts & Analysis

Asker Healthcare Group AB (publ) (ASKER.ST) has a trailing P/E of 43.06x and a forward P/E of 22.65x. This places ASKER.ST in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

ASKER.ST trades with 43.06x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether ASKER.ST looks overvalued or undervalued.

ASKER.ST's P/E of 43.06x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

ASKER.ST's trailing EPS is SEK 1.78 and forward EPS is SEK 2.94. Reported earnings growth is 69.80%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Asker Healthcare Group AB (publ) generated for each share. ASKER.ST's trailing EPS is SEK 1.78, and investors usually prefer EPS that is positive and growing over time.

Asker Healthcare Group AB (publ) has a market cap of SEK 29.36B, making ASKER.ST a large-cap stock based on the current market value shown on Worldtickers.

ASKER.ST's latest stock price on Worldtickers is SEK 76.65. The latest move is -SEK 0.05 or -0.07%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

ASKER.ST's quote includes a latest price of SEK 76.65. The market open is SEK 76.75. Previous close is SEK 76.70. The intraday range is SEK 75.20 to SEK 77.05.

ASKER.ST is down in the latest quote, with a move of -SEK 0.05 or -0.07%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

ASKER.ST generated SEK 18.01B in trailing revenue. Revenue growth is 17.50%, which helps show whether demand is expanding or slowing.

ASKER.ST's revenue growth is 17.50%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, ASKER.ST shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is SEK 715.00M.

Gross margin is 41.32%. Margins show how efficiently Asker Healthcare Group AB (publ) turns revenue into profit.

Asker Healthcare Group AB (publ) carries SEK 6.48B and holds SEK 777.00M in cash.

ASKER.ST holds SEK 777.00M on its balance sheet.

ASKER.ST's book value per share is SEK 18.22.

Yes, Asker Healthcare Group AB (publ) pays a dividend of SEK 0.39 per share annually. The dividend yield is 51.00%. The payout ratio is 21.91%.

ASKER.ST's dividend yield is 51.00%. Its payout ratio is 21.91%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for ASKER.ST. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Asker Healthcare Group AB (publ)'s investor relations materials.

Institutions hold 87.02% of ASKER.ST shares. Insiders hold 2.36% of shares. Ownership mix helps investors understand how much of Asker Healthcare Group AB (publ) is held by professional investors and company insiders.

ASKER.ST has 383.04M shares outstanding. Float shares are 228.08M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for ASKER.ST, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for ASKER.ST is SEK 2.94. Earnings growth is 69.80%. Revenue growth is 17.50%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

ASKER.ST's trailing EPS is SEK 1.78. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

ASKER.ST is in the Healthcare sector. Its earnings multiple is 43.06x. Its latest displayed growth metric is 17.50%. Compare these figures with sector peers before deciding whether Asker Healthcare Group AB (publ) is stronger or weaker than average.

ASKER.ST trades at SEK 76.65. The stock trades at 43.06x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Asker Healthcare Group AB (publ)'s fundamentals.

ASKER.ST risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. No single stock should be evaluated without portfolio context.

ASKER.ST should be compared with companies in Medical Distribution. Its earnings multiple is 43.06x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Asker Healthcare Group AB (publ) (ASKER.ST) operates in Healthcare, specifically Medical Distribution. Asker Healthcare Group AB (publ) provides medical supplies, devices, and equipment and related solutions that support patient care. The company supplies and distributes fittings and equipment; veterinary equipment; surgical and diagnostic instruments; medical supplies and equipment for urology, ultrasound diagnostics, laser treatment, and regenerative medicine; medical equipment for operating rooms, polyclinics, and day surgeries; hygiene equipment; equipment and products for beauty clinics; defibrillators and woun

ASKER.ST trades on Stockholm. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

ASKER.ST stock is priced in SEK on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Asker Healthcare Group AB (publ)'s official website listed on Worldtickers is www.asker.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Asker Healthcare Group AB (publ) employs about 4.89K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Asker Healthcare Group AB (publ) is headquartered in Danderyd, Sweden. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

ASKER.ST is in the Healthcare sector and the Medical Distribution industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

ASKER.ST has traded between SEK 58.64 and SEK 105.48 over the past 52 weeks. At SEK 76.65, it is 27.33% below the high and 30.71% above the low. The 52-week range helps gauge long-term price momentum.

ASKER.ST is below both its 50-day and 200-day moving averages, which is a common downtrend signal. Its 50-day moving average is SEK 79.04 and its 200-day moving average is SEK 77.94.

ASKER.ST's RSI is 41.31. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

ASKER.ST's latest RSI reading is 41.31, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for ASKER.ST is near SEK 73.70. Key resistance is near SEK 85.75. Breaks above resistance or below support can change the short-term technical setup.

ASKER.ST's nearest reported support level is SEK 73.70. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

ASKER.ST's nearest reported resistance level is SEK 85.75. A breakout above resistance can improve momentum, especially when volume confirms the move.

ASKER.ST trades about 381.96K shares daily on average. The latest displayed volume is 384.32K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

ASKER.ST's MACD is -0.66, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

ASKER.ST is below both its 50-day and 200-day moving averages, which is a common downtrend signal. RSI is 41.31 (neutral). MACD is bearish. Nearest support is around SEK 73.70. Resistance is around SEK 85.75. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is SEK 79.82 (-3.97% from price). MA50 is SEK 79.04 (-3.03% from price). MA200 is SEK 77.94 (-1.66% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. ASKER.ST's MA20 is SEK 79.82. MA50 is SEK 79.04. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

ASKER.ST's pivot is near SEK 76.93. Support is near SEK 73.70. Resistance is near SEK 85.75. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for ASKER.ST is near SEK 70.74. The next upper resistance zone is near SEK 79.79. These levels help define risk and possible follow-through zones after a breakout or breakdown.

ASKER.ST's Bollinger range is roughly SEK 74.11 to SEK 85.53. Band width is near 14.31%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

ASKER.ST's ATR-based typical daily range is about 3.69%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 384.32K shares. Average volume is about 381.96K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

ASKER.ST's all-time high shown on Worldtickers is SEK 131.22. Its all-time low is SEK 58.64. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.